This Article Full Text Full Text (PDF) All Versions of this Article: 40/6/847    most recent 01.HYP.0000037979.53963.8Fv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wiemer, G. Articles by Heitsch, H. Search for Related Content PubMed PubMed Citation Articles by Wiemer, G. Articles by Heitsch, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections ACE/Angiotension receptors Endothelium/vascular type/nitric oxide

(Hypertension. 2002;40:847.)
© 2002 American Heart Association, Inc.

Scientific Contributions

AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium

Gabriele Wiemer; Lawrence W. Dobrucki; Febee R. Louka; Tadeusz Malinski; Holger Heitsch

From DG Cardiovascular Diseases/Medicinal Chemistry, Aventis Pharma Deutschland GmbH (G.W., H.H.), Frankfurt/Main, Germany; and the Department of Chemistry and Biochemistry, Ohio University (L.W.D., F.R.L., T.M.), Athens, Ohio.

Correspondence to Dr Holger Heitsch, Aventis Pharma Deutschland GmbH, DI&A LG Chemistry–Medicinal Chemistry, Building G 878, D-65926 Frankfurt am Main, Germany. E-mail holger.heitsch{at}aventis.com

Recently, we demonstrated that the heptapeptide angiotensin-(1–7) (Ang-[1–7]) exhibits a favorable kinetic of nitric oxide (NO) release accompanied by extremely low superoxide (O₂^-) production. In this report we describe AVE 0991, a novel nonpeptide compound that evoked effects similar to Ang-(1–7) on the endothelium. AVE 0991 and unlabeled Ang-(1–7) competed for high-affinity binding of [¹²⁵I]-Ang-(1–7) to bovine aortic endothelial cell membranes with IC₅₀ values of 21±35 and 220±280 nmol/L, respectively. Stimulated NO and O₂^- release from bovine aortic endothelial cells was directly and simultaneously measured on the cell surface by selective electrochemical nanosensors. Peak concentrations of NO and O₂^- release by AVE 0991 and Ang-(1–7) (both 10 µmol/L) were not significantly different (NO: 295±20 and 270±25 nmol/L; O₂^-: 18±2 and 20±4 nmol/L). However, the released amount of bioactive NO was 5 times higher for AVE 0991 in comparison to Ang-(1–7). The selective Ang-(1–7) antagonist [D-Ala⁷]-Ang-(1–7) inhibited the AVE 0991–induced NO and O₂^- production by 50%. A similar inhibition level was observed for the Ang II AT₁ receptor antagonist EXP 3174. In contrast, the Ang II AT₂ receptor antagonist PD 123,177 inhibited the AVE 0991–stimulated NO production by 90% but without any inhibitory effect on O₂^- production. Both NO and O₂^- production were inhibited by NO synthase inhibition (70%) and by bradykinin B₂ receptor blockade (80%). AVE 0991 efficiently mimics the effects of Ang-(1–7) on the endothelium, most probably through stimulation of a specific, endothelial Ang-(1–7)-sensitive binding site causing kinin-mediated activation of endothelial NO synthase.

Key Words: nitric oxide synthase • endothelium • angiotensin • nitric oxide

This article has been cited by other articles:

				M. B.L. Carvalho, F. V. Duarte, R. Faria-Silva, B. Fauler, L. T. da Mata Machado, R. D. de Paula, M. J. Campagnole-Santos, and R. A.S. Santos Evidence for Mas-Mediated Bradykinin Potentiation by the Angiotensin-(1-7) Nonpeptide Mimic AVE 0991 in Normotensive Rats Hypertension, October 1, 2007; 50(4): 762 - 767. [Abstract] [Full Text] [PDF]

				N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF]

				I. F. Benter, M. H. M. Yousif, J. T. Anim, C. Cojocel, and D. I. Diz Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H684 - H691. [Abstract] [Full Text] [PDF]

				R. Faria-Silva, F. V. Duarte, and R. A.S. Santos Short-Term Angiotensin(1-7) Receptor Mas Stimulation Improves Endothelial Function in Normotensive Rats Hypertension, October 1, 2005; 46(4): 948 - 952. [Abstract] [Full Text] [PDF]

				S. V. B. Pinheiro, A. C. Simoes e Silva, W. O. Sampaio, R. D. de Paula, E. P. Mendes, E. D. Bontempo, J. B. Pesquero, T. Walther, N. Alenina, M. Bader, et al. Nonpeptide AVE 0991 Is an Angiotensin-(1-7) Receptor Mas Agonist in the Mouse Kidney Hypertension, October 1, 2004; 44(4): 490 - 496. [Abstract] [Full Text] [PDF]

				R. A.S. Santos, A. S. Haibara, M. J. Campagnole-Santos, A. C. Simoes e Silva, R. D. Paula, S. V.B. Pinheiro, M. de Fatima Leite, V. S. Lemos, D. M.R. Silva, M. T. Guerra, et al. Characterization of a New Selective Antagonist for Angiotensin-(1-7), D-Pro7-Angiotensin-(1-7) Hypertension, March 1, 2003; 41(3): 737 - 743. [Abstract] [Full Text] [PDF]